The role of today’s CMO is not only limited to marketing activities but also responsible for being a revenue driver of a business. A CMO faces many challenges, and quality insights and networking opportunities are hard to come by. The CMO Talks Spin-off -A Round Table Initiative by MarketsandMarkets aims to rectify those pain points by bringing together top thought leaders in the business world – exploring the dimensions and ramifications of this new age of ever-evolving leadership roles.

The healthcare sector is accelerating on a trajectory from ubiquitous treatment to truly personalized treatment. The advent of precision medicine has paved ways for customization and preventive health strategy development by utilizing the genetic information of the individual along with ethnicity, environment exposures, medical history and more. Surging trends in tailoring care have been a driving force for extensive research in this field from data research to target drug discovery.

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 9th - 10th March 2023, in London, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Leading our way back to the ambitious research collaboration, Human Genome Project has paved ways in transforming biology and biological discovery. As a result of which, the fundamentals of Genomics and Proteomics have proven to be an indispensable resource in the sphere of medical research and new diagnostic strategies. The swift growth in high throughput technologies used for genomic and proteomic profiling has factored breakthroughs for a much-anticipated personalized medicine approach for complex diseases.

With the advent of new technological advancements in medical research and diagnostic strategies, early disease diagnosis and prevention has witnessed a medical revolution. We are proud to present to you our ‘OncoGene’ ConfEx in London scheduled on 9th – 10th March 2023. This ConfEx is an assemblage of 3 inextricably linked conferences like 7th Annual Next-Gen Immuno-Oncology Conference, Next-Gen Genomics and Proteomics Conference and Precision Medicine Conference which will accommodate diverse sessions on cutting edge discussions via Presentations, Exhibitions, Speaker QnAs, Panel discussions or Breakout sessions.

Over the years, the role of a CRO has grown to become a single point of contact in an organization, besides driving better integration and alignment between all revenue-related functions. Moreover, CROs today are responsible for catering to revenue-generating processes and connecting various revenue-related tasks in an organization. They are also demonstrating effective leadership to drive predictable growth.

The current market scenario demands effective sales leadership of the CRO to surpass through recessionary times and maintain the business continuity cycle. Join our host, Deb Deep Sengupta, Global President & Chief Revenue Officer, Cloud4C Services | Board Advisor | Investor | Former CEO SAP India & South Asia, in conversation with our guest speaker, Simon Chassar, Chief Revenue Officer, Claroty, to uncover the role of a CRO in effective sales leadership.

The role of today’s CMO is not only limited to marketing activities but also responsible for being a revenue driver of a business. A CMO faces many challenges, and quality insights and networking opportunities are hard to come by. The CMO Talks Spin-off Round Table Initiative by MarketsandMarkets aims to rectify those pain points by bringing together top thought leaders in the business world – exploring the dimensions and ramifications of this new age of ever-evolving leadership roles.

MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th - 9th February 2023 in San Diego, USA. This event will have an introduction to turning biomarkers into companion diagnostics.

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product & drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on microbiome vs probiotics and the link between them.

MarketsandMarkets is here with a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2023 Confex on the 8th - 9th February 2023 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.

The paints & coatings market is expected to be a $179 billion market in 2025. The growth of end-use industries such as architectural, general industrial, protective, and automotive & transportation is driving the paints & coatings market growth.
A host of attractive, high growth opportunities such as Smart Coatings, NanoCoatings, Anti-Icing Coating, anti-microbial coatings, polyurea coatings, UV coatings, etc could be pursued. Participants such as Paints & Coatings Manufacturer, Resin, Solvent, and Additives manufacturers can benefit from this unprecedented growth over the next 5 years.

The role of today’s CMO is not only limited to marketing activities but also responsible for being a revenue driver of a business. A CMO faces many challenges, and quality insights and networking opportunities are hard to come by. The CMO Talks Spin-off -A Round Table Initiative by MarketsandMarkets aims to rectify those pain points by bringing together top thought leaders in the business world – exploring the dimensions and ramifications of this new age of ever-evolving leadership roles.

The industrial and services robot market is expected to grow at over `18% to be a $176 billion market in 2025. Numerous engines are expected to fuel its growth – A.I in Robotics, Cloud Robotics, Connected Autonomous Systems, Enterprise Robotic Automation, COBOTS, Bio robotics, Exoskeletons, Biped and Humanoids, Unmanned Aerial Systems, Advanced Vision Systems, Implantable sensors for Robotics as well as others.

A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics, Robotics in industrial monitoring, IOT/Industry 4.0 etc could be pursued.

The sustainable packaging market is estimated to grow at a healthy CAGR of 6-7% in the coming 5 years, driven by demand from flexible packaging and food & beverage industry.

Key Drivers & Opportunities shall include:

Government Initiatives: Initiative to minimize waste and encouraging recycling by various governmental bodies across geographies.

The role of today’s CMO is not only limited to marketing activities but also responsible for being a revenue driver of a business. A CMO faces many challenges, and quality insights and networking opportunities are hard to come by. The CMO Talks Spin-off -A Round Table Initiative by MarketsandMarkets aims to rectify those pain points by bringing together top thought leaders in the business world – exploring the dimensions and ramifications of this new age of ever-evolving leadership roles.

The telecom industry is in a turbulent phase owing to several platform developments. Customers now have far higher expectations for connectivity, speed, support, convenience, and availability, which call for higher service quality. Japan is ahead of everyone in the race to implement 5G services, and the direction of mobile connection is clear now. An innovative new mobile network that might significantly reduce the cost and expand the flexibility of cellular services was soft launched by newcomer Rakuten Mobile. With its emerging cloud radio access network (Cloud-RAN), Rakuten can leverage off-the-shelf hardware by virtualizing radio network operations.

The EV passenger car market is expected to reach nearly 39 million units by 2030, starting from around 8 million units in 2022, at a CAGR of 21.7%. Similarly, electric commercial vehicles are expected to grow at a CAGR of 31.4% from 0.3 million units in 2022 to around 3 million units by 2030. Major factors contributing to the stupendous growth are government net zero targets and incentives, OEM efforts to shift their offerings to electric, improving EV and related technologies (such as charging, batteries, drivetrain etc.), lower cost of operations of EVs, and growing consumer sentiment toward EV adoption.

The 3D printing market is expected to grow at a CAGR of 22.5% to reach USD 34.8 billion market in 2026. Numerous engines are expected to fuel its growth – Digital Manufacturing, Industrial Internet of Things (IIOT)x, Industrial 3D Printing, Automated 3D Printing, 3D food Printing, 3D Mapping and Modelling, Continuous Composites, 3D Print Robots, Metamaterials, 3D Metal Printing. The industry has gone through a revolution over the last 5 to 10 years. Though it's a consumer-oriented technology, it has evolved into a viable industrial manufacturing solution. The market map consists of various providers in the 3D ecosystem, namely, 3D printers, software, services, and material providers, along with research institutes.

Over the last 50 years, the bioprocessing industry has witnessed tremendous change, overcoming many challenges to increase efficiency and productivity throughout the development and manufacturing process. These efforts have been particularly focused to elicit major advancements for cell lines, culture media, and downstream processes used to produce therapeutics.

MarketsandMarkets is proud to announce the 3rd Annual MarketsandMarkets World Pharma Supply Chain and Cold Chain Logistics Virtual Conference on 20th-21st October 2022

Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking space, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.

MarketsandMarkets is proud to announce the 5th Annual Real-World Evidence and Life Sciences Conference to be held on October 20-21, 2022 in Boston, USA.

Real-world data and real-world evidence are poised to keep making strides in 2022.
The emergence of this pandemic has posed severe financial constraints on pharma-biopharma companies in several countries. In this regard, RWE solutions have proven to be extremely useful, as they allow industrial and academic researchers to monitor patients using digitally connected platforms while assisting to organize and evaluate clinical data for regulatory submissions.

Augmented reality and Virtual reality market in the current year is expected to have a market size of USD 37.0 billion and can reach up to USD 114.5 billion by 2027, the end of 5-year forecast period at a market growth of 25.3% rate.

The smart manufacturing market is expected to reach USD 228 billion by 2027. Numerous enabling technologies are expected to fuel its growth – Condition Monitoring, Artificial Intelligence, Digital Twin, Industrial 3D Printing, Collaborative Robots, Industrial Cybersecurity, Warehouse Management Systems, Manufacturing Execution System and Automated Guided Vehicle. 

The cybersecurity market is expected to grow at over ~9.7% to be a USD 345 billion market in 2026. Numerous engines are expected to fuel its growth – advanced persistent threat, identity and access management, encryption, threat intelligence, security and information event management, network access control, intrusion detection and prevention system, data discovery and risk and compliance management.

Emerging agricultural trends involve new technologies and strategies that become more advanced over time. There have been significant changes in the agriculture sector over the past several decades and new technologies have also been introduced. All these factors have led to an expansion of the sector. Recent agricultural advances have made farming activities more comfortable and acceptable for farmers. Developments or trends such as these benefit not only the growth of agriculture, but also the lives of farmers.

Plant-based foods are one of the fastest growing food categories, growing by double digits in 2019, and are expected to reach $68.4 billion worldwide by 2026. The growth of this market is driven by a wide range of factors, including the increasing intolerance for animal proteins among consumers, the growing vegan population, and the booming number of venture investments in plant-based foods. Further, the increasing number of new products developed by manufacturers of plant-based proteins and emerging economies, such as Asian-Pacific, Latin America, and Middle East & Africa, are expected to provide new opportunities for players in this market.

Enterprises today are constantly adapting to evolving customer needs, significant cost pressures, intense competition and novel disruptions in supply chains. To tackle these challenges, it’s crucial to be agile, hyper-productive and resilient. While this has led to enterprises investing heavily in Digital Transformation & Intelligent Automation, process mining can provide granular data to improve overall process visibility that can enable enterprises to address gaps in realizing value from their investments.

This exclusively curated event will help to identify challenges & opportunities in intelligent process automation and explore how banks & insurance companies in the Philippines can optimize their workforce productivity & efficiency to gain immense value out of the application of diverse robotic process automation (RPA) tools & technologies.

 

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

Urgent disruptions are driving change across all industries, requiring leaders to embrace new ways of thinking while capitalizing on opportunities that are short-lived and limited. These disruptions are already compelling, as B2B companies seek to transform 50% of their revenues from old to new revenue sources, creating opportunities worth upwards of $25 trillion by 2030. 

The market for Agricultural Biologicals is projected to grow at a CAGR of 13.7% to reach USD 24.6 billion by 2027. Strong initiatives towards organic farming and the increasing awareness of environmental protection have encouraged the demand for agricultural biologicals in the agriculture industry.

The big data and analytics market is expected to grow at over `11% to be a USD 273 billion market in 2026. Numerous growth engines are expected to fuel its adoption – the increasing use of Internet of Things (IoT) devices among organizations, increasing availability of data across the organizations to gain deeper insights to remain competitive, and increasing digital transformation initiatives among enterprises.

The digital health market is expected to grow at over ~28% CAGR to be close to ~350 billion market in 2025. Numerous engines are expected to fuel its growth – telehealth and telemedicine, mHealth, Digital Therapeutics, cloud computing, Healthcare IoT, wearable technologies, virtual assistants, Augmented and virtual reality as well as others.

The in-vitro diagnostics market is expected to reach USD 96.07 billion by 2025 at a CAGR of 2.6% during the forecast period. The rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, growing awareness regarding diseases diagnosis in developing regions, increasing adoption of fully automated and POC instruments in developed regions, and growing R&D investments by industry players to launch new IVD products are the major factor supporting growth of the in-vitro diagnostics market.

The development of condition-specific markers and tests, growing significance of companion diagnostics, POC tests with multiplexing capabilities are the factors expected to provide significant growth opportunities in the coming years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the composites market, as seen through the lens of eminent CXOs in this space.

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

The cloud computing market is expected to grow at over ~18% to be a USD 832 billion market in 2025. Numerous engines are expected to fuel its growth - Cloud HPC, Cloud Contact Center, Chatbots, Container-as-a-Service, AI Platform, Enterprise Content Management, Cloud-based CRM, and Learning Management System.

MarketsandMarkets presents the New Economy Series - Fireside Chats aimed at providing cutting-edge business ideas to share a 'new' economy with a significant driving force to "give growth" in conjunction with sustainability. The series brings the top industry experts where they discuss actionable insights on new revenue growth opportunities emerging from disruptions in the marketplace - which can help businesses navigate the emerging challenges.

As Sustainable Aviation concept becomes reality and gains traction, electrification and alternative fuels for aircraft are the next big trends with the potential market opportunity of USD 50 billion in the next 5 to 7 years. Challenges faced by aviation industry such as carbon emissions and noise pollution will act a major opportunity for sustainable aviation market. Key trends such as urban air mobility, electric aircraft and sustainable aviation fuels are expected to impact the future revenues of key players within this industry.

Cybersecurity is the protection of internet-connected systems such as hardware, software and data from cyberthreats. The practice is used by individuals and enterprises to protect against unauthorized access to data centers and other computerized systems.

Cybersecurity is the protection to defend internet-connected devices and services from malicious attacks by hackers, spammers, and cybercriminals

• The global plant-based food market is expected to reach 77.8 billion U.S. dollars in 2025. The forecast projects that by 2030 the market will have more than doubled. For 2022, the model expects a market worth 44.2 billion U.S. dollars.
   
• Plant-based or plant-forward eating patterns focus on foods including not only fruits & vegetables, but also nuts, seeds, oils, whole grains, legumes, and beans.

MarketsandMarkets presents the New Economy Series - Fireside Chats to provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem. Episodes in this series unveil how global market and technological disruptions impact the economy. As it directly influences industries, actionable insights from industry experts can help businesses navigate through emerging challenges and act accordingly towards growth.

In this episode, we deep-dived into the future of the green chemicals industry in conjunction with sustainability and decarbonization – with the primary focus on CCUS, BIO, and Green Hydrogen. With the growing adoption of green chemicals to minimize the overall carbon footprint, there stands a lucrative market growth opportunity of US$ 232 billion by 2032.

Register Now to unlock the impending advantage in the green chemicals market!

#DisruptionDialogues Podcast focuses on various upcoming disruptions that are changing the operating landscape of global businesses. This podcast series is designed to introduce the subject of disruption to like-minded leaders who would share insights on a host of challenges being faced by a plethora of industries, and the solutions being pitted to tackle them. In this decade alone, we expect to see each B2B company transforming 50% of their revenues. To survive these business disruptions, companies need to analyze their business processes and external environment to ascertain whether they are well equipped to rise to these challenges. According to MarketsandMarkets estimate, these disruptions are expected to create new revenue opportunities worth US$ 25 trillion by 2030. 

MarketsandMarkets presents the New Economy Series - Fireside Chats to provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem. Episodes in this series unveil how global market and technological disruptions impact the economy. As it directly influences industries, actionable insights from industry experts can help businesses navigate through emerging challenges and act accordingly towards growth. 

In this episode, we deep-dived into the future of the CCUS and DAC technologies in conjunction with sustainability and reducing carbon footprint – with the primary focus on driving the CO2 emissions to zero. With the growing initiatives towards carbon capture, there stands a lucrative revenue opportunity of $170 million by 2025 awaits in CO2 capture alongside a billion-dollar plus market by 2030. 

Stay tuned to unlock the impending advantage in the CCUS market!

With new digital transformation trends impacting the industries, marketing community is going through a rapid change and it’s imperative to boost up the innovation process ten folds of the expected. Advancement in customer data has elevated the pressure to prove ROI. The scope of the role has increased enormously in today's leadership. A CMO’s function has evolved to promote versatile growth, and along with their responsibility to remould sales and marketing strategies, the need for a CMO to meet business acumen is utmost challenging.

Join us at the MarketsandMarkets CMO Summit London on 27th -28th June 2022. Hear from top marketers about how leading brands are adapting to the shifting landscape, behavioural trends, products, and services. Over the two days, marketing moguls will share tips and best practices on emerging technologies, automation in driving customer experience, and various opportunities and disruptions in Marketing world.

The smart manufacturing market are expected to reach USD 384 billion market in 2025. Numerous enabling technologies are expected to fuel its growth – Condition Monitoring, Artificial Intelligence, Digital Twin, Industrial 3D Printing, Collaborative Robots, Industrial Cybersecurity, Warehouse Management Systems, Manufacturing Execution System and Automated Guided Vehicle. 

This Crystal Ball event focuses on learning more about the most promising opportunities in the Smart Manufacturing ecosystem, as seen through the lens of eminent CXOs in this space.

#DisruptionDialogues Podcast focuses on the various upcoming disruptions that are changing the operating landscape of global businesses. This podcast series is designed to introduce the subject of disruption to like-minded leaders who would share insights on a host of challenges being faced by a plethora of industries, and the solutions being pitted to tackle them. In this decade alone, we expect to see each B2B company transforming 50% of their revenues. To survive these business disruptions, companies need to analyze their business processes and external environment to ascertain whether they are well equipped to rise to these challenges. According to MarketsandMarkets estimate, these disruptions are expected to create new revenue opportunities worth US$ 25 trillion by 2030.

Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 23rd-24th, June 2022, in Boston, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Over last several years, there has been a rapid development of technologies, methods, and applications of Single-Cell Analysis. Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and ultimately guide diagnosis and treatment option. Single-cell sequencing is one of the most promising methods to study the tumor cells in cancer progression. These technologies have progressed intensely, and vigorously over the past five years.

Witness an overwhelming participation of the key decision makers from academia, pharmaceutical and bio-pharmaceutical industies working in the areas of research and development, manufacturing, market access, commercialization and supply chain under one roof.

MarketsandMarkets’ Biopharma Series is a platform providing an opportunity to experts from the industry, regulators, academia and technology providers to discuss innovations, challenges, best practices, use-cases and future aspects in the area of single cell analysis and next-gen immune-oncology.

CSO’s role shelters everything from defining a corporate strategy, to anchoring it with clients, partners, and the ecosystem at large. Confronted with disruptive trends in technologies, ever more stringent regulations, and increasingly complex organizational structures, executive leaders need to continuously develop and implement more robust strategies to respond, adapt and get ahead. That’s where the role of the Chief Strategy Officer comes into play.

The Blockchain market is expected to grow at over 67% to be a USD 39.7 billion market in 2025. Blockchain is expected to be driven by factors beyond crypto mining such as smart contracts, self-sovereign identity, decentralized storage, and non-fungible tokens.

The Global semiconductor market was valued at US$ 554 billion in 2021, an increase of 26% percent from 2020. Analog segment was the major growth rate contributor, followed by Memory, and Logic. It is expected that the semiconductor market in 2020 will cross US$600 billion, primarily driven by the increasing semiconductor content across the end-user industries including automotive, consumer electronics, data centers, Industrial, Healthcare, Energy and Power etc.

The 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference scheduled to be held on 16th - 17th June 2022 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers.

The ecology of human microbiome is known to be associated with both phenotype and environment. With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

However, inadequate research and regulatory policies in the human microbiome are some of the factors which restrain the progress. Learn about microbial innovation and applying the new microbiome findings along with the regulatory pathways for better therapeutic development. Also, witness discussions on Microbiome vs probiotics and the link between them.

MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2022 Confex on the 16th - 17th June 2022 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.

With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy.  With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

The CRO oversees operations, sales, company development, advertising and marketing, pricing, and revenue management. They recognize enhancing income overall performance, developing great product and pricing strategy, and delivering customer satisfaction. Their function is becoming increasingly essential in recurring revenue models like subscription-oriented models and retrieving customers as well as organising commercial enterprise relationships with new ones.

They are the individual in charge of a company’s revenue streams. Leveraging knowledge of the roles both sales and advertising play in driving growth, they have remaining accountability in aligning all sales-generating departments and building strategic partnerships.

Discussion on USD 20.0 billion FOOD SAFETY TESTING market & it’s current and future market potential.

Increasing Outbreaks of Foodborne Illness, Stringent Food Safety Regulations & Technological Advancements in Food Testing & other influencing factors.

Onsite rapid food tests Allergen sensors for consumers and other Disruptive Trends.

Food Services, Meat, Poultry, and Seafood applications and other emerging cases.

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

Overview:

• The EV charging stations market is expected to reach nearly 31 million units by 2027, starting from 2 million units in 2020, at a CAGR of 47%. Major factors contributing to the stupendous growth are rapidly growing EV sales worldwide, improving charging technologies and consistent consumer sentiment toward EV adoption.
• Key opportunities such as development of fast charging system, wireless power transfer, smart charging infrastructure, interoperability and standardization of components would ensure promising growth for the market players over the next 5-7 years. Adjacent market trends such as smart grids, IoT, 5G communication and Artificial Intelligence would ensure a robust charging infrastructure.
• This Crystal Ball event focuses on learning more about the most promising opportunities in the EV Charging Station ecosystem, as seen through the lens of eminent CXOs in this space.

The paints & coatings market is expected to be a $179 billion market in 2025. The growth of end-use industries such as architectural, general industrial, protective, and automotive & transportation is driving the paints & coatings market growth.
A host of attractive, high growth opportunities such as Smart Coatings, NanoCoatings, Anti-Icing Coating, anti-microbial coatings, polyurea coatings, UV coatings, etc could be pursued. Participants such as Paints & Coatings Manufacturer, Resin, Solvent, and Additives manufacturers can benefit from this unprecedented growth over the next 5 years.

MarketsandMarkets New Economy Series - Fireside Chat on Decarbonization Decoding $95 Billion Of Opportunity in Recycled Plastics MarketsandMarkets presents the New Economy Series - Fireside Chats to provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem.

The CRO oversees operations, sales, company development, advertising and marketing, pricing, and revenue management. They recognize enhancing income overall performance, developing great product and pricing strategy, and delivering customer satisfaction. Their function is becoming increasingly essential in recurring revenue models like subscription-oriented models and retrieving customers as well as organising commercial enterprise relationships with new ones.

They are the individual in charge of a company’s revenue streams. Leveraging knowledge of the roles both sales and advertising play in driving growth, they have remaining accountability in aligning all sales-generating departments and building strategic partnerships.

In a post-pandemic world, organizations need to not only adapt to technological changes but also build on a long-term revenue mindset. There is a need to move from working in silos to working together in alignment so that all the revenue-related departments pay off. Join us as we understand how the CRO can bring about this change in our CRO Talk Series. Register here and catch our CRO Talk Series: Module 4 - What Experience Makes For The Perfect CRO?

Join MarketsandMarkets with our host, Deb Deep Sengupta - Chief Revenue Officer | Board Advisor | Investor | Former CEO SAP India & South Asia, an industry veteran with a proven track record of building “Winning Culture”, in conversation with our guest speaker Eric Duffaut, President and Global Head of Field & Marketing, FINASTRA with over 30 years of experience in sales, consulting services, marketing, & customer support with SAP & Oracle to unravel the disruptive role of the CRO.

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

Various laboratory automation software solutions are expected to offer lucrative growth opportunities such as lab information management solutions is poised to grow at 2X the analytical tech industry during 2021-2025; driven by numerous engines – rising research expenditure of pharma-biotech cos, stringent compliance to quality control regulations by drug manufacturing and applied industries, expansion & modernization of healthcare infrastructure across emerging markets, and greater utilization of integrated lab platforms globally

From automated platforms and integrated platforms improving overall operational efficiency to data management & AI-driven analytical solutions that help customers with improved lab outcomes, the laboratory automation will continue to evolve and provide a host of attractive, high growth opportunities

High growth markets which contribute to 20% of your revenues today will contribute 80% in the next 5 years. Identify these new revenue sources at MarketsandMarkets’ s Crystal Ball event

The end product sales in bioproduction market are expected to grow at over `15% to be a $305 Bn market in 2025. Numerous engines are expected to fuel its growth – Cell Therapy, Gene Therapy, Monoclonal Antibodies, Vaccines, biosimilars and bio betters, plasma therapy as well as others.

A host of attractive, high growth opportunities such as single use systems, Lab Scale and CGMP manufacturing and R&D, Crispr and other Gene editing tools and technologies, Novel downstream bioprocessing methods etc. could be pursued. Participants such as CROs, CMOs, Bioprocess solutions manufacturers, Biobanks, automation technology providers etc. can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Bioproduction ecosystem, as seen through the lens of eminent CXOs in this space

The cybersecurity market is expected to grow at over ~9.7% to be a USD 345 billion market in 2026. Numerous engines are expected to fuel its growth – advanced persistent threat, identity and access management, encryption, threat intelligence, security and information event management, network access control, intrusion detection and prevention system, data discovery and risk and compliance management.

As businesses transitioned from office to remote operations, demand for endpoint security, cloud security solutions and disaster recovery solutions have surged. This demand has unlocked opportunities for cybersecurity vendors, cloud platform providers (CSPs), consulting firms, system integrators and managed service providers (MSPs). Participants such as CIOs, CTOs, CISOs, enterprise solution and service providers, and CSPs can benefit from this unprecedented growth over the next 5 years. This Crystal Ball event focuses on learning more about the most promising opportunities in the cloud computing space, as seen through the lens of eminent CXOs in this space

MarketsandMarkets presents the New Economy Series  - Fireside Chats that provide actionable insights on new revenue growth opportunities emerging from disruptions in the ecosystem. Episodes in the series will cover Market & Technological disruptions, their impact on the economy and how industries can navigate emerging challenges so that they can adapt and grow from them.

The CRO oversees operations, sales, company development, advertising and marketing, pricing, and revenue management. They recognize enhancing income overall performance, developing great product and pricing strategy, and delivering customer satisfaction. Their function is becoming increasingly essential in recurring revenue models like subscription-oriented models and retrieving customers as well as organising commercial enterprise relationships with new ones.

They are the individual in charge of a company’s revenue streams. Leveraging knowledge of the roles both sales and advertising play in driving growth, they have remaining accountability in aligning all sales-generating departments and building strategic partnerships.

The CRO oversees operations, sales, company development, advertising and marketing, pricing, and revenue management. They recognize enhancing income overall performance, developing great product and pricing strategy, and delivering customer satisfaction. Their function is becoming increasingly essential in recurring revenue models like subscription-oriented models and retrieving customers as well as organising commercial enterprise relationships with new ones.

They are the individual in charge of a company’s revenue streams. Leveraging knowledge of the roles both sales and advertising play in driving growth, they have remaining accountability in aligning all sales-generating departments and building strategic partnerships.

The telecommunication landscape has changed drastically, with B2B units of telecom operators thriving to be able to operate at cloud speed with the global deployment of 5G supported by cloud-native core networks.

5G and edge cloud networks greatly increase their relevance and attractiveness as service delivery partners. To reach this new level of efficiency, accuracy, and security, organizations need real-time visibility and intelligence into their organizational and operational data. The increasing business demand for enhancing network efficiency, high speed, and virtualization of network security is expected to make the 5G a dominant market.

Given the importance of innovation to economic development and growth, the diffusion of inventions is of great interest to economists and policymakers a. Here the technology transfer comes into play which promote exchange of knowledge between academia and industry, to strengthen the transfer of novelties from labs to the real-world practices.

Tech transfer has its own deep rooted challenges viz, dissemination of technology, considered cost effectiveness for newer technology, adoption, and various regulatory and marketing related activities. Based on the addressal and solutions to these areas, MarketsandMarkets is coming up with the 1 day tech transfer virtual event on “How to create and describe inventions in a more commercial ready way’ on 30th March 2022.

DNA sequencing is the process of determining the precise order of the nucleotides in DNA. Genome sequencing helps us to understand the genetic biology and has vast potential for medical diagnosis and treatment. DNA sequencing technologies have gone through at least three "generations": Sanger sequencing and Gilbert sequencing were first-generation, pyrosequencing was second-generation, and Illumina sequencing is next-generation.

Advancements in NGS platforms, declining costs of genome sequencing and growing incidence of cancer and increasing applications of NGS in cancer research are the key factors supporting the growth of the market.

The plant-based protein market is expected to grow at over ~7.2% to be a USD 15.6 billion market in 2026. Increase in demand for meat substitute and vegan-friendly products to widen growth prospects for plant-based protein. Furthermore, innovations and developments related to plant-based protein to encourage the vegan trend and increase in investments & collaborations in the plant-based food business are expected to fuel the growth.

Dairy alternatives are food & beverage products that are like certain types of dairy-based products in terms of texture and flavor, as well as the nutritional benefits they offer. The market is expected to grow at over ~10.3% to be a USD 40.6 billion market in 2026. The increasing number of lactose-intolerant and dairy-allergic consumers has accelerated the growth of the dairy alternatives market.

Based on the survey on 1,000 hospitals in 33 countries, European Centre for Disease Prevention and Control (ECDC) estimates that that on any given day, one in 18 patients in a European hospital has healthcare-associated infection (HAIs). Most the countries (26 out of 33) reported the major three types of HAIs: pneumonia and lower respiratory tract infection, surgical site infection and urinary tract infection.

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

MarketsandMarkets is extremely delighted to announce its 3rd Annual Infectious Disease Diagnostics and Molecular Diagnostics Conference scheduled to be held on 23rd - 24th March 2022 in London.

The Smart Grid market is expected to grow at a CAGR of 19.1% to be a USD 103.4 billion market in 2026 from 39.0 billion in 2021. Numerous factors are expected to fuel this growth: supportive regulatory framework of governments, improved grid reliability and efficient outage response, increasing awareness about carbon footprint management, and strong focus on modernization of aging grid infrastructure

Global digital Agriculture Market size is estimated to grow from USD 5.6 billion in 2020 and is projected to reach USD 6.2 billion by 2021, recording a CAGR of 9.9%. The shift in consumer preferences to higher standards of food safety and quality and increase in demand for agriculture food products are some of the driving factors for the market. Moreover, increased farm mechanization and developing digital  agriculture infrastructure are expected to increase the adoption of digital agriculture among the farmers.

New medicine for Orphan and Rare Diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination,monitoring treatment reaction and early diagnostics.

The treatment options for cancer, such as chemotherapies and radiation therapy, although have more side effects, are more widely used as compared to immunotherapies. The former are all based on destroying cancer cells by irradiation, chemotherapy, or surgery. While they can effectively kill or remove cancer cells, the use of these treatments is often limited because they tend to destroy healthy cells in large numbers as well. As immunotherapies involve the mechanism of enhancing the body’s own immunity using man-made proteins such as monoclonal antibodies, they are accepted worldwide over other treatment options.

The IoT sensors market size is expected to reach USD 29.6 billion by 2026 from USD 8.4 billion in 2021, at a CAGR of 28.6%. Numerous engines are expected to fuel its growth – Increasing use of sensors in IoT applications due to cost and size reduction, and technological advancement, and Introduction of 3GPP Release 13 and Release 14 specifications are the key factors driving the growth of the IoT sensors market. The Growth of Internet penetration rate and High demand for connected and wearables devices are factors propelling the growth of the IoT sensors market.

Owing to the rapid reduction in the sensor size and high adoption of microelectromechanical systems (MEMS) technology, sensors are finding applications in automotive, healthcare, and consumer products. This has played a major role in the growth of the overall sensors market. During the last 5 years, smaller sensors have rapidly been deployed in devices such as smartphones, drones, wearables, and robots.

This Crystal Ball event focuses on learning more about the most promising opportunities in the IOT Sensor ecosystem, as seen through the lens of eminent CXOs in this space.

The in-vitro diagnostics market is expected to reach USD 96.07 billion by 2025 at a CAGR of 2.6% during the forecast period. The rising geriatric population and the subsequent growth in the prevalence of chronic and infectious diseases, growing awareness regarding diseases diagnosis in developing regions, increasing adoption of fully automated and POC instruments in developed regions, and growing R&D investments by industry players to launch new IVD products are the major factor supporting growth of the in-vitro diagnostics market.

The development of condition-specific markers and tests, growing significance of companion diagnostics, POC tests with multiplexing capabilities are the factors expected to provide significant growth opportunities in the coming years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the composites market, as seen through the lens of eminent CXOs in this space.

The digital health market is expected to grow at over ~28% CAGR to be close to ~350 billion market in 2025. Numerous engines are expected to fuel its growth – telehealth and telemedicine, mHealth, Digital Therapeutics, cloud computing, Healthcare IoT, wearable technologies, virtual assistants, Augmented and virtual reality as well as others.

A host of attractive, high growth opportunities such as Artificial Intelligence and analytics, Precision medicine,  patient engagement, remote patient monitoring, 5G, Automation, Medical Robots, Healthcare 4.0 etc could be pursued. Participants such as Network connectivity and hardware providers, OEMs, infrastructure service providers, Software, Platform and service vendors, medical device manufacturers, system integrators, hospital and health systems, Health insurance payers, Pharmaceutical and biotechnology companies etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the digital health ecosystem, as seen through the lens of eminent CXOs in this space.

• Composites market is expected to grow from US$ 88.01 Billion in 2021 to US$ 126.35 Billion in 2026 at CAGR 7.5%. Numerous engines are expected to fuel its growth such as aerospace, Automotive, wind energy, construction repair, sporting Goods etc.  Composites are increasingly used in the aerospace and automotive industry as they decrease weight and increase fuel efficiency.
• In Wind Energy Industry turbines with high energy production capacity require lightweight wind blades as heavier blades affect the production capacity due to their weight constraints. Hence, manufacturers are focusing on the use of lightweight materials in wind turbine design.

The UAV Market is expected to reach USD 58.4 billion by 2026, at a CAGR of 16.4% during the forecast period. The UAV market is growing at a significant rate across the world, and a similar trend is expected to be observed during the forecast period. Increased adoption of UAV in civil and commercial applications, rising demand for UAV in military applications, surged use of UAV in disaster relief operations and improvements in regulatory frameworks related to drone operations are factors which are fuelling the growth of the UAV market.

With the incorporation of new technologies such as artificial intelligence, sense and avoid systems, and cloud computing in UAV, their demand is expected to increase further. The incorporation of artificial intelligence in UAV has not only enhanced their capabilities but has also enabled them to carry out several activities such as takeoff, navigation, data capture, data transmission, and data analysis without human intervention.

In recent years, there has been an extraordinary leap in knowledge of the human genome and its role in health and disease. Advanced genetic sequencing has been revolutionizing discoveries across life sciences and has been accelerating technology that offers ultra-high throughput, scalability, and speed in modern medicine

The 3D printing  market are expected to grow at over 18% to be a $30 billion market in 2025. Numerous engines are expected to fuel its growth – Digital Manufacturing, Industrial Internet of Things (IIOT)x, Industrial 3D Printing, Automated 3D Printing, 3D food Printing, 3D Mapping and Modelling, Continuous Composites, 3D Print Robots, Metamaterials, 3D Metal Printing. 3D printing has gone through a revolution over the last 5 to 10 years. Though it is a consumer-oriented technology, it has evolved into a viable industrial manufacturing solution. The market map consists of various providers in the 3D ecosystem, namely, 3D printers, software, services, and material providers, along with research institutes.

A host of attractive, high growth opportunities such as Smart Factory, Rapid Prototyping, Continuous Composite, 4D Printing, AI & Machine Learning, 3D printing  in  IOT/Industry 4.0 etc could be pursued. Participants such as 3D Printers Manufacturer, OEMs, Software and Service Vendors, Material and Metal Machine providers etc can benefit from this unprecedented growth over the next 5 years.This Crystal Ball event focuses on learning more about the most promising opportunities in the 3D Printing  ecosystem, as seen through the lens of eminent CXOs in this space.

The cybersecurity market is expected to grow at over ~9.7% to be a USD 345 billion market in 2026. Numerous engines are expected to fuel its growth – advanced persistent threat, identity and access management, encryption, threat intelligence, security and information event management, network access control, intrusion detection and prevention system, data discovery and risk and compliance management.

As businesses transitioned from office to remote operations, demand for endpoint security, cloud security solutions and disaster recovery solutions have surged. This demand has unlocked opportunities for cybersecurity vendors, cloud platform providers (CSPs), consulting firms, system integrators and managed service providers (MSPs). Participants such as CIOs, CTOs, CISOs, enterprise solution and service providers, and CSPs can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the cloud computing space, as seen through the lens of eminent CXOs in this space.

The 5G services market is expected to grow at nearly 30%, to be USD 249.2 billion in size by 2026. Numerous growth trends are expected to fuel its adoption, such as increasing mobile network data traffic, need to transform the mobile broadband experience, accelerating digital transformation of verticals, and development of smart infrastructure across the globe. 

Increasing demand for high reliability and low latency networks, unleashing massive IoT ecosystem and critical communications services, and demand to move beyond connectivity and collaborate across sectors to deliver new, rich services will provide attractive, high growth opportunities in the 5G services market. Participants such as CIOs, CTOs, CMOs, 5G network solution and service providers, and system integrators can benefit from this unprecedented growth over the next five years.

This crystal ball event focuses on learning more about the most promising opportunities in the 5G services space, as seen through the lens of eminent CXOs in this space.

The AR market is expected to grow to be a USD 77 billion market in 2025 driven by key use cases in healthcare, retail etc. Gaming and lifestyle are prominent AR apps that are being downloaded by numerous users. Gaming contributes to about 25% of the total AR app downloads, while lifestyle contributes ~20%.

The VR market is expected to reach USD 21 billion by 2025 at a CAGR of ~28% from 2020 to 2025. Due to the increasing demand for hardware devices, the VR market has witnessed high growth. The VR content creation market is expected to witness growth driven by the inflow of content to fulfil the requirements of different applications using VR HMDs. This will be a massive boost to the growth of the VR market.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AR/VR ecosystem, as seen through the lens of eminent CXOs in this space.

A platform for key decision makers to re-imagine the framework; model strategy in the new-normal and discuss how forward-looking executives can highlight anomalies and revamp their business models and invest their resources dynamically, all while exploring 25 trillion worth of disruption in this decade!

Organizations that identify potential blind spots and white space opportunities emerging from the technological disruptions and market interconnections will always have the first-mover advantage.

MarketsandMarkets, along with SCIP, invite the innovative leaders in Strategy and Market Intelligence/Competitive Intelligence (MI/CI) to join us at this exclusive webinar, where our leadership experts will share the disruptive trends and ways to leverage them into the changing business landscape. 

This virtual webinar is a unique platform for leaders & decision makers to discuss the framework to model strategy in this new economy. Identify new revenue streams and blind spots and develop a breakthrough for their 2022 goals! 

The smart manufacturing market are expected to reach USD 384 billion market in 2025. Numerous enabling technology are expected to fuel its growth – Condition Monitoring, Artificial Intelligence, Digital Twin, Industrial 3D Printing, Collaborative Robots, Industrial Cybersecurity, Warehouse Management Systems, Manufacturing Execution System and Automated Guided Vehicle. 

A host of attractive, high growth opportunities such as IoT in Manufacturing, AR/VR in Manufacturing, Industrial Robotics, Blockchain in Manufacturing, Warehouse Robotics & Automation, and 5G Infrastructure could be pursued. Participants such as technology providers, machine/equipment providers, Software & ICT players, System Integrator, and end user industry can be benefited from this unprecedented growth over the next 5 years  

This Crystal Ball event focuses on learning more about the most promising opportunities in the Smart Manufacturing ecosystem, as seen through the lens of eminent CXOs in this space.

The cloud computing market is expected to grow at over ~18% to be a USD 832 billion market in 2025. Numerous engines are expected to fuel its growth - Cloud HPC, Cloud Contact Center, Chatbots, Container-as-a-Service, AI Platform, Enterprise Content Management, Cloud-based CRM, and Learning Management System.

As businesses transitioned from office to remote operations, demand for remote desktop infrastructure and SaaS-based applications—Office 365 and G Suite, Dropbox, Slack, Zoom, Salesforce CRM and other business continuity and disaster recovery solutions surged. This demand has unlocked opportunities for Cloud Service Providers (CSPs), hyperscalers, and Managed Service Providers (MSPs). Participants such as CIOs, CTOs, CMOs, OEM’s, enterprise solution and service providers, and CSPs can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the cloud computing space, as seen through the lens of eminent CXOs in this space.

CSO’s role shelters everything from defining a corporate strategy, to anchor it with clients, partners, and the ecosystem at large. With that to align the organization to the strategy and enable each team and individual to contribute to the execution plays a key role in mapping the growth of organizations.

Where pandemic has made the whole process challenging as strategy rely completely on internal alignment and communication. Disruptive innovative technologies are now being introduced to overcome challenging times. To gain competitive advantage, businesses must incorporate these technologies along with long-term strategies into their business models.

The EV charging stations market is expected to reach nearly 31 million units by 2027, starting from 2 million units in 2020, at a CAGR of 47%. Major factors contributing to the stupendous growth are rapidly growing EV sales worldwide, improving charging technologies and consistent consumer sentiment toward EV adoption.

Key opportunities such as development of fast charging system, wireless power transfer, smart charging infrastructure, interoperability and standardization of components would ensure promising growth for the market players over the next 5-7 years. Adjacent market trends such as smart grids, IoT, 5G communication and Artificial Intelligence would ensure a robust charging infrastructure.

This Crystal Ball event focuses on learning more about the most promising opportunities in the EV Charging Station ecosystem, as seen through the lens of eminent CXOs in this space.

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

The businesses have witnessed changes like never before and so do the Marketing world. It has become imperative for professionals to change the way of thinking and analyzing the market potential and challenges. CMO’s of today are gearing up with new insights, creativity, and analytics to turn business profitable ad meaningful.

The blockchain market is expected to grow at over 67% to be a USD 39.7 billion market in 2025. Blockchain is expected to be driven by factors beyond crypto mining such as smart contracts, self-sovereign identity, decentralized storage, and non-fungible tokens.

The blockchain as a service (BaaS) model enables end-users to evaluate the potential of the technology with relatively minimal investment prior investing on the full-fledged on-premise deployment model. BaaS model is attractive among large companies and companies with limited financial strength to test its capabilities for actionable intelligence for real-time decision making. Participants such as CIOs, CTOs, CMOs, AI, Automation, Analytics, IoT solution and service providers, and system integrators can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the blockchain space, as seen through the lens of eminent CXOs in this space.

Single-cell analysis is crucial for discovering population heterogeneity, identifying minority sub-populations of interest, and discovering unique properties of individual cells. Microfluidic systems operate on a scale comparable to cell width and are capable of manipulating single cells. Single-cell sequencing is a new and powerful technique for studying the evolution and variety of most malignancies, as well as the involvement of circulating tumour cells in cancer progression. These techniques have begun to answer critical problems in cancer biology that have been difficult to answer using bulk tumour measurements. The technology and applications of single-cell analysis have advanced dramatically in the last five years.

CSO’s role shelters everything from defining a corporate strategy, to anchor it with clients, partners, and the ecosystem at large. With that to align the organization to the strategy and enable each team and individual to contribute to the execution plays a key role in mapping the growth of organizations.

Where pandemic has made the whole process challenging as strategy rely completely on internal alignment and communication. Disruptive innovative technologies are now being introduced to overcome challenging times. To gain competitive advantage, businesses must incorporate these technologies along with long-term strategies into their business models.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.

Our 5th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress to be held on 26 - 29 October 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

Boston Scientific is excited to launch their first ‘Partnering for Prevention’ event, a 3-hour virtual interaction discussing the ever-important topic, Infection Control in Endoscopy.

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

From computer vision systems and predictive analytics improving manufacturing operations to self-learning algorithms that help us make better decisions, the AI/ML algorithms will continue to evolve and provide a host of attractive, high growth opportunities. Participants such as CIOs, CTOs, CMOs, AI hardware providers, AI solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AI space, as seen through the lens of eminent CXOs in this space.

In 2017, a report from UN, reported that 51 trillion plastic particles are present in our oceans; 500 times more than the stars in the galaxy.

Many states in US have announced ban on single use plastics. European Union passed a tax of €0.80 (about $1.00) per kilogram on non-recycled plastic packaging waste. EU Directive 2018/852 on packaging and packaging waste calls for 50% recycling of plastic packaging by 2025 and 55% by 2030.  China’s open sword policy has banned import of more than 24 types of plastic waste. As a consequence of the above it is predicted that crude oil demand for petrochemicals can shrink by more than 20% by 2040.

How realistic are these predictions and how effective are targets set by governments. For these to become a reality plastic recycling has to become viable and to achieve this viability following questions need to be answered:      

MarketsandMarkets is proud to announce the 5th Edition Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 20-22, 2021. The expanding utilization of Real World Evidence to speed up data driven choices is further developing the clinical trial experience, but healthcare in general. 

While there is extraordinary promise in utilizing Real World Data and Real World Evidence, there are some significant challenges that should be survived: potential bias of information and data sources, inadequate data sets and absence of harmonization of data between RWE data sources, access to such data, and lack of standards in evaluating the worth of Real World Evidence data. Further developing RWE is key for pharma organizations in drug development. There was big data available pre covid and now with the access data due to covid, technology enablers like AI and ML are important for big data analysis and evidence generation. Every stakeholder has faced a some impact and had to adjust. 

The businesses have witnessed changes like never before and so do the Marketing world. It has become imperative for professionals to change the way of thinking and analyze the market potential and challenges. Marketers of today are gearing up with new insights, creativity, and analytics to turn business profitable ad meaningful. The Marketing summit aims to tap the creativity aspect of professionals and determine how they can use resources to generate revenue and meet business purpose. How will the leaders adapt to paradigm shift? Evolving role of leaders in different industries, trend identification and strategy, enhancing B2B customer experience and regulatory concerns are the key points event will cover.

Participate and learn from top level executives at 2nd Edition MarketsandMarkets Marketing Innovation and Leadership Virtual Summit to be held on October 21 2021!

More than just a term, Mergers and Acquisition process encompasses far more complex procedures and after transaction challenges. Numerous challenges like cultural fit, integration, infrastructure, etc. has led organizations to adopt a more clear and strategic approach to these MnA transactions. These challenges not only force the organization to bring changes to their business process but also mission and vision of the stakeholders.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals being overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hygiene, health, and safety. The increasing healthcare expenditure in North America being the major factor driving the demand and uptake of antiseptics and disinfectants in the region.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respiratory care devices, and reusable hemodialysis machines can increase the chances of healthcare associated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilizing medical devices.

Market intelligence provides a comprehensive perspective of any industry’s depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today’s fast-paced economy. Missing up on these advantages can be the difference between success and failure.

The pandemic has disrupted healthcare systems frameworks around the world, with hospitals be-ing overwhelmed due to the increasing influx of patients. The spread of COVID-19 has prodded a surge in demand for cleaning and disinfection products due to the growing awareness about hy-giene, health, and safety.

The utilization of reprocessed equipment to disinfect or sterilize medical devices is higher than normal now since improper decontamination of surgical instruments, endoscopic devices, respira-tory care devices, and reusable hemodialysis machines can increase the chances of healthcare as-sociated infections. Patient-to-patient pathogen transmission via medical devices can be entirely prevented by properly sterilising medical devices

Nanopore sequencing and its application to pandemic epidemiological survey of SARS CoV-19 and strains surveillance. Now, with COVID therapeutic manufacturing taking priority, there is a big desire to accelerate other clinical pipeline because of ample opportunity for new medicine.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September 2021 will hold discussions on trending technologies and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

The paints & coatings market is expected to be a $179 billion market in 2025. The growth of end-use industries such as architectural, general industrial, protective, and automotive & transportation is driving the paints & coatings market growth.
A host of attractive, high growth opportunities such as Smart Coatings, NanoCoatings, Anti-Icing Coating, anti-microbial coatings, polyurea coatings, UV coatings, etc could be pursued. Participants such as Paints & Coatings Manufacturer, Resin, Solvent, and Additives manufacturers can benefit from this unprecedented growth over the next 5 years.

The adhesives market is expected to be a $70 billion market in 2025. The major drivers for the market are increased demand for adhesives in the medical industry, increasing demand for adhesives & sealants from the building & construction industry, and growth in the appliances industry.

A host of attractive, high growth opportunities such as EV Adhesives, Electronic Adhesives, medical adhesives, etc could be pursued. Participants such as Adhesives Manufacturer, Resin, Curing Agent, Additives & fillers manufacturers can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Paints & Coatings  ecosystem, as seen through the lens of eminent CXOs in this space.

Market intelligence provides a comprehensive perspective of any industry’s depth, both economically and philosophically. Organizations cannot afford to scrimp on acquiring market knowledge in today’s fast-paced economy. Missing up on these advantages can be the difference between success and failure.

The industrial and services robot market are expected to grow at over `18% to be a $176 billion market in 2025. Numerous engines are expected to fuel its growth – A.I in Robotics, Cloud Robotics, Connected Autonomous Systems, Enterprise Robotic Automation, COBOTS, Biorobotics, Exoskeletons, Biped and Humanoids, Unmanned Aerial Systems, Advanced Vision Systems, Implantable sensors for Robotics as well as others.

A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics, Robotics in industrial monitoring, IOT/Industry 4.0 etc could be pursued. Participants such as system integrators, OEMs, Software and Programming vendors, End of Arm tool manufacturers, Drives and control system providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Robotics ecosystem, as seen through the lens of eminent CXOs in this space.

Given the importance of innovation to economic development and growth, the diffusion of inventions is of great interest to economists and policymakers a. Here the technology transfer comes into play which promote exchange of knowledge between academia and industry, to strengthen the transfer of novelties from labs to the real-world practices.

The advancement and evolution of Technologies has resulted businesses to adapt and incorporate these technologies into their business processes. With the evolution of Robotics and Automation, many Manufacturing firms are undergoing tremendous amount of Digital Transformation which has led to change in the ways of doing business. To increase Efficiency and Effectives, an emerging concept of Plant Digitization is getting into the spotlight. The power of Data Collection to Data Visualization has helped corporates to make necessary decisions right from the business strategy to on floor embedding of sensors for better understanding of machine behaviors.

The industries are facing continual changes and challenges. Owing to the need to digitize and digitalize, there are constant economic pressures and regulatory complexities that make compliance an everyday problem. Corporate goals are also focused on production and efficiency as industrial service providers and producers seek to catch up with the current global demand while maintaining the required safety targets to adhere to industry standards. In a bid to understand more about this topic, HIMA would like to invite you to take part in a small focus group to understand how Digitalization and Safety had impacted you in your daily work or organization.

With an increasing amount of data, it has become vital for organizations to incorporate Big Data Analytics into their business processes. The continuous evolution Big Data Tools & Technologies has led to increase in its presence in day-to-day operations of several industries. The market holds enormous number of opportunities as well as challenges and it has become essential to keep track of these and incorporate them into our data strategy. The event focuses on Addressing the data quality issues, Big Data architectures to be incorporated for efficient and effective processes, Tools & Technologies that is uplifting the market and building an effective Testing Environment.

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Virtual Congress-US Edition to be held on 28th-1st July 2021 would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.

•The 3D printing  market are expected to grow at over 18% to be a $30 billion market in 2025. Numerous engines are expected to fuel its growth – Digital Manufacturing, Industrial Internet of Things (IIOT)x, Industrial 3D Printing, Automated 3D Printing, 3D food Printing, 3D Mapping and Modelling, Continuous Composites, 3D Print Robots, Metamaterials, 3D Metal Printing. 3D printing has gone through a revolution over the last 5 to 10 years. Though it is a consumer-oriented technology, it has evolved into a viable industrial manufacturing solution. The market map consists of various providers in the 3D ecosystem, namely, 3D printers, software, services, and material providers, along with research institutes.

A host of attractive, high growth opportunities such as Smart Factory, Rapid Prototyping, Continuous Composite, 4D Printing, AI & Machine Learning, 3D printing  in  IOT/Industry 4.0 etc could be pursued. Participants such as 3D Printers Manufacturer, OEMs, Software and Service Vendors, Material and Metal Machine providers etc can benefit from this unprecedented growth over the next 5 years.

•This Crystal Ball event focuses on learning more about the most promising opportunities in the 3D Printing  ecosystem, as seen through the lens of eminent CXOs in this space.

The AR market is expected to grow to be a USD 77 billion market in 2025 driven by key use cases in healthcare, retail etc. Gaming and lifestyle are prominent AR apps that are being downloaded by numerous users. Gaming contributes to about 25% of the total AR app downloads, while lifestyle contributes ~20%.

The VR market is expected to reach USD 21 billion by 2025 at a CAGR of ~28% from 2020 to 2025. Due to the increasing demand for hardware devices, the VR market has witnessed high growth. The VR content creation market is expected to witness growth driven by the inflow of content to fulfil the requirements of different applications using VR HMDs. This will be a massive boost to the growth of the VR market.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AR/VR ecosystem, as seen through the lens of eminent CXOs in this space.

Organizations must make consumer service the starting point for product creation to satisfy consumer’s ever-changing needs. Learning and using human-centred approaches in a creative manner will help to solve business challenges in BFSI industry. Innovation in Business strategies by incorporating a structured design thinking format with empathy at its core is the most important aspect in today’s world for business growth. Explore new business ideas with a human centered design strategy at 2nd Edition MarketsandMarkets Design Thinking – BFSI Virtual Summit, scheduled to be held on 16th-17th June. Join us for a two-day virtual conference where business leaders will share their perspectives and insights that have enabled their organization's development and profitability. 

Various laboratory automation software solutions are expected to offer lucrative growth opportunities such as lab information management solutions is poised to grow at 2X the analytical tech industry during 2021-2025; driven by numerous engines such as rising research expenditure of pharma-biotech cos, stringent compliance to quality control regulations by drug manufacturing and applied industries, expansion & modernization of healthcare infrastructure across emerging markets, and greater utilization of integrated lab platforms globally

From automated platforms and integrated platforms improving overall operational efficiency to data management & AI-driven analytical solutions that help customers with improved lab outcomes, the laboratory automation will continue to evolve and provide a host of attractive, high growth opportunities

Participants such as CIOs, CTOs, CMOs, automation platform providers, digital solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years

This Crystal Ball event focuses on learning more about the most promising opportunities in the lab automation space, as seen through the lens of eminent CXOs in this space

The digital health market is expected to grow at over ~28% CAGR to be close to ~350 billion market in 2025. Numerous engines are expected to fuel its growth – telehealth and telemedicine, mHealth, Digital Therapeutics, cloud computing, Healthcare IoT, wearable technologies, virtual assistants, Augmented and virtual reality as well as others.

A host of attractive, high growth opportunities such as Artificial Intelligence and analytics, Precision medicine,  patient engagement, remote patient monitoring, 5G, Automation, Medical Robots, Healthcare 4.0 etc could be pursued. Participants such as Network connectivity and hardware providers, OEMs, infrastructure service providers, Software, Platform and service vendors, medical device manufacturers, system integrators, hospital and health systems, Health insurance payers, Pharmaceutical and biotechnology companies etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the digital health ecosystem, as seen through the lens of eminent CXOs in this space.

Pharmaceutical supply chain and logistics faced the hardest disruptions during initial COVID era. Now, with COVID therapeutic manufacturing taking priority, there also is a big desire to accelerate other clinical pipeline because of the ample opportunity for new medicine. While some companies were able to cope with their contingencies plan in place, the other followed risk mitigation. It is now essential for the pharma supply chain and logistics to follow the redundancy routes.  

Technology and creativity continue to alter the working environment. Consumer demands are becoming more challenging every day, and keeping up with trends can be overwhelming. Today's leadership of the CMO is about promoting growth, and their responsibility for sales and marketing strategies that needed to meet business acumen is utmost challenging

Digitization, growing robotics, and modern business models have revolutionized most sectors, especially the automotive industry. Linked cars with automatic piloting have forced the digitalisation of the automotive industry, showing the undeniable value of data in automotive market.

Growing interest in 3D printing in the automotive industry, starting from the possibility of fast prototyping, this technology is proving vital role in the industry.

After the successful foureditions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies.

The virtual event will present detailed case studies and interactive discussions in cell culture, scale-up, continuous processing, recovery, purification, process and product characterization, and formulation.

5G is paving the way in many smart opportunities and is revolutionizing the technology world. Breakthrough technologies for the 5G deployment and infrastructure are going to change the game.

The conference is focused on few of the major questions such as what is the Influence of ML and AI on 5G? The privacy and security risk? How to tap into 5G monetization opportunity? Understanding business implications of booming trends of 5G

MarketsandMarkets is proud to announce the 4th Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference to be held on 22- 23 April, 2021.

While the 3rd annual virtual conference had discussions on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers, the 4th Annual conference will focus on discussion about the application of RWD/RWE across the life cycle. The event will discuss Impact of COVID-19 on the real-world generation and making sense of the Electronic Health Records data for COVID-19.

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

COVID-19 has changed the business landscape for everyone. In these constantly evolving and changing times, it is essential for business organizations to stay ahead of time and create newer strategies to optimize revenue. Disruptive innovative technologies are now being introduced to overcome challenging times. To gain competitive advantage, businesses must incorporate these technologies along with long-term strategies into their business models.

The 8th Edition Biomarker and Companion Diagnostics Virtual Conference scheduled to be held on 25 - 26 March 2021 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. 

Based on the survey on 1,000 hospitals in 33 countries, European Centre for Disease Prevention and Control (ECDC) estimates that that on any given day, one in 18 patients in a European hospital has healthcare-associated infection (HAIs). Most the countries (26 out of 33) reported the major three types of HAIs: pneumonia and lower respiratory tract infection, surgical site infection and urinary tract infection.

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

Digital Transformation has accelerated immensely in the past few months, Fintech and Blockchain are at the center of this paradigm shift from Traditional Banking to Digital Banking. With the Financial Services and Banking sector bracing themselves for uncertain times, the industries have witnessed advanced innovations, larger investments, and greater productivity. This has led to a rise of Fintech and Blockchain Technology in the Middle East to adopt the changing economy trends. 

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key for making the treatment decisions, it needs to be quicker, précised, and accurate.

The end product sales in bioproduction market are expected to grow at over `15% to be a $305 Bn market in 2025. Numerous engines are expected to fuel its growth – Cell Therapy, Gene Therapy, Monoclonal Antibodies, Vaccines, biosimilars and biobetters, plasma therapy as well as others.

A host of attractive, high growth opportunities such as single use systems, Lab Scale and CGMP manufacturing and R&D, Crispr and other Gene editing tools and technologies, Novel downstream bioprocessing methods etc could be pursued. Participants such as CROs, CMOs, Bioprocess solutions manufacturers, Biobanks, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Bioproduction ecosystem, as seen through the lens of eminent CXOs in this space

The Artificial Intelligence (AI) market is expected to grow at over `36% to be a $190 Bn market in 2025. Numerous engines are expected to fuel its growth – increase in amount of big data, increased adoption of cloud-based applications and services, increase in demand for virtual assistants, emergence of new use cases as well as others.

From computer vision systems and predictive analytics improving manufacturing operations to self-learning algorithms that help us make better decisions, the AI/ML algorithms will continue to evolve and provide a host of attractive, high growth opportunities. Participants such as CIOs, CTOs, CMOs, AI hardware providers, AI solution and service providers, automation technology providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the AI space, as seen through the lens of eminent CXOs in this space.

The industrial and services robot market are expected to grow at over `18% to be a $176 billion market in 2025. Numerous engines are expected to fuel its growth – A.I in Robotics, Cloud Robotics, Connected Autonomous Systems, Enterprise Robotic Automation, COBOTS, Biorobotics, Exoskeletons, Biped and Humanoids, Unmanned Aerial Systems, Advanced Vision Systems, Implantable sensors for Robotics as well as others.

A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics, Robotics in industrial monitoring, IOT/Industry 4.0 etc could be pursued. Participants such as system integrators, OEMs, Software and Programming vendors, End of Arm tool manufacturers, Drives and control system providers etc can benefit from this unprecedented growth over the next 5 years.

This Crystal Ball event focuses on learning more about the most promising opportunities in the Robotics ecosystem, as seen through the lens of eminent CXOs in this space.

Witness the significant development of microbiome, probiotics and prebiotics research alongside their applications relating to difficulties like therapeutic information understanding, speculation and administrative obstacles looked by the experts. The convergence between developing innovation and disclosure with the setting of consumer intrigue. Recognize the non-distinguished dysbiosis, to find the expected territories under examination for interests in Gut and Skin microbiome and its part as an indicative instrument of drug revelation. 

Process of marketing does not stop with the product launch but continues thereafter to ensure enhanced customer experience and customized solutions throughout product's lifecycle. Smart marketing solutions opted by organizations contribute to the holistic view over the depth of any industry, economically and contemporarily. 

New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

Single-cell sequencing (SCS) is new effective tool for investigating the evolution and variety of most cancers and role of circulating tumor cells in cancer progression. These methods have started to unravel key questions in cancer biology which have been hard to deal with for bulk tumor measurements. Over the span of 5 years, there has been exceptional development in technology and applications of Single-cell analysis.

Recent advances in single cell technologies have opened new avenues to signify the intra-tumor cell heterogeneity, identify rare cell kinds, degree of mutation, and, ultimately guide diagnosis and treatment option.

Where does your success begin? With constant development emerging in global marketing scenario, things have become far more complicated then it seems. Smarter marketing solutions opted by the Chief Marketing professionals give the holistic view over the depth of any industry, economically and ideologically. These solutions help organizations improve their measurement and strategic planning. Smarter the solutions, better the outcomes.

MarketsandMarkets is proud to announce the Pharma Cold Chain Logistics - Virtual Conference to be held on 5th - 6th November 2020. Increasing pressure faced by pharmaceutical companies to make their supply chain more efficient, cost effective, focused and more agile has made the industry increasingly competitive in the recent years. With the wide consumption of cold chain logistics in the pharmaceutical industry, efficient temperature controlled logistics is mandatory for quality assurance of drugs. Now with the additional road-blocks and problems due to the pandemic, the pharma supply chain is faring, specifically transportation.

Big data enables us to understand the information contained within the data and also helps us to identify data which is most important for business decision making. The continuous evolution of Big Data technology has led to the growing use of AI, ML and cloud architecture. With newer trends emerging, it is essential to keep track of these and incorporate them into our data strategy.

In the past decade, many scientific breakthroughs have been achieved through research including success in recent years of cancer immunotherapy with monoclonal antibodies, cancer vaccines, adoptive cell therapy and immune-checkpoint therapy. Personalized immunotherapy with various combinations will be the next promising strategy for the future cancer treatment direction.

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.

MarketsandMarkets is proud to announce the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 22nd -23rd, 2020.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.

The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness.

The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.

Point-of-care testing (POCT) is a growing technology. Today, you may see POCT in a hospital with hand held gadgets or small testers in emergency department, extensive care setting, popular clinical wards and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

Technology, digitization and globalization are disrupting conventional business models. The design and customer experience functions are witnessing an exponential shift. In today’s rapidly evolving world, it is essential to connect with the customers to stay ahead and gain competitive advantage. The BFSI sector has experienced a turbulent period of digital disruption in the recent past. Banking and Financial Institutes needs to explore the customer expectations and needs on a deeper level with unconventional innovative solutions. It is at this point that Design Thinking in finance comes into play! Design Thinking helps Banks and Financial Institutes understand the people for whom they are designing their products or services. Design Thinking in BFSI enables the integration of technology with a human centered approach into the business strategy.

Industrial revolution influences mission-critical applications in business processes and the manufacturing companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, which goes a long way with customers. This has made the revolution the need of the hour!

The successful inaugural event of MarketsandMarkets Industry 4.0 Conference-Chicago, focused on the impact of IIOT and Cybersecurity, by addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world.

The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment facilities that facilitate the safety of employees from exposure. Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. 

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

MarketsandMarkets is proud to announce the 4th Annual High Potent Medicines Conference to be held on 14th - 15th September 2020 . This conference would address the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

HR is one of the key entities of all organization and technology disruption is the primary focus for professional development. HR leaders must develop the capacity to transform, support business goals and build the workforce of the future.

MarketsandMarkets Chief HR Tech Virtual Summit on 13-14 August 2020 is bringing together chief HR Tech influencers and leaders from a wide range of industries to access the latest HR tech insights and transformation success strategies required to embrace change in 2020 and beyond. The conference is focusing on synergy between technology and human resources to strike for remarkable business results. 

What is the future of technology in the Automotive industry? Automotive companies are embracing connected and smart technologies to offer safer and future-ready vehicles by investing in Advanced Driver Assistance Systems (ADAS). The battleground to win the customers is one of the driving forces for automotive manufacturers and OEMs to adopt the technology and lead the marketplace. However, the safety concerns and regulations around autonomous vehicles, communications systems, etc are limiting the acceptance of the technology.

Harnessing data has become integral to any organization’s growth and development. The continuous evolution of Big Data technology has led to the growing use of AI, ML and cloud architecture. With newer trends emerging, it is essential to keep track of these and incorporate them into our data strategy. The Global Pandemic has also caused tech giants to invest in collecting, analysing and strategizing on transforming their businesses through digitization. To leverage the opportunities and address industry challenges, the masterclass focuses on building efficient data strategies, accelerating business values through data-driven transformation, developing a stable cloud computing architecture, using AI and ML effectively and overcoming data management challenges during COVID-19.

New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases scheduled to be held on 9th -10th July 2020 will provide valuable and necessary platform for uplifting knowledge at the forefront of drug analysis. Over the course of the conference, internationally-renowned speakers can describe how their analysis journeys have developed the response towards up to date challenges. The attending specialists and trade partners will offer an incredible networking expertise.

 

Increasing pressure faced by pharmaceutical companies to make their supply chain more efficient, cost effective, focused and more agile has made the industry increasingly competitive in the recent years. With the mandate for serialization, strict quality regulations and increasing importance of patient centricity for pharma companies to follow, it is essential to navigate from complex supply chain ecosystem to simpler processes. Now with the additional roadblocks and problems due to the pandemic (global outbreak), the pharma supply chain is faring. Major problem being the  impact of COVID-19 on two of the largest global producers of active pharmaceutical ingredients (APIs) and generics: China and India.

Due to growing concerns about COVID-19, the 3rd Annual MarketsandMarkets Next Gen IO Congress is going fully virtual this year. We are disappointed that we are not able to come together in person in June for this event, but we are so thrilled to see you on an online platform. We are working together to create a virtual conference that will be beneficial and engaging for speakers, attendees and sponsors/exhibitors.

See the Post Show report of our 2nd Annual here

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In our conference of 2017, we assessed the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.

Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.

See the Post Show report of our inaugural event here

As the era of personalized medicine is fast approaching, healthcare is becoming more personalized and tailored to the patient. Digital health platforms has helped converting medical data into a continuous, reliable and complete picture of the patient's health, and data analytics algorithms process information that is specific to individuals, leading to more personal and effective solutions.

MarketsandMarkets are proud to host its inaugural “Digital Transformation and Precision Medicine Virtual Conference” which will be held on 11th-12th June 2020.  The conference will focus on the innovative and disruptive digital health technologies and futuristic business models transforming the precision medicine industry. The conference further aims in bringing experts from the academics, pharma, start-ups, hospitals and technology providers who will share their recent technological breakthroughs in personalized medicine.

Blockchain & Fintech has the potential to disrupt and transform numerous industries. These technologies enable the trustless collaboration, reducing complexity and creating secure and immutable information. With the help of the blockchain and fintech, the financial industry has witnessed advanced innovations, larger investments and greater productivity.

In recent years, the understanding regarding the role of epigenetic factors has been improved. Epigenetic research has been generally determined by technological advancement, remarkably high-throughput sequencing technologies. In spite of the fact that technologies have been improved and have been responsible for the advances in the field, several challenges remain.

Our 5th Annual Epigenetics- Digital Conference will discuss the solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis.

The advancement of delicate CTC and cfDNA identification led to innovations that has empowered the improvement of liquid biopsies with numerous clinical applications, including-screening for nearness of disease, patient stratification and treatment determination, monitoring treatment reaction and early diagnostics.

MarketsandMarkets Virtual Conference on Liquid Biopsy will unite the pioneers from Diagnostics organization, Experts from Pharmaceutical and Bio-Pharma companies, Researchers and professors from renowned universities to address the challenges in early detection of tumor cells and the potential of liquid biopsies to screen, monitor and treatment of the diseases.

Get your groove back! Join us along with most prominent techy geeks across the industry and master online marketing skills for your business. Looking for a new virtual strategy for your business? Join us at MarketsandMarkets Master class for Digital Marketing professionals from your home on 7th & 8th May 2020.

According to a study published by The Lancet Infectious Diseases, researchers estimated that globally 3 in every 1,000 people carry latent multidrug-resistant tuberculosis (MDR-TB), with the prevalence of being 10 times higher among children younger than 15 years of age.

As outlined in the independent review on Antimicrobial Resistance, AMR is predicted to kill 10 million people every year by 2050 without action. From rare pathogens to pandemic prevention, explore the latest techniques and technologies that are shaping today’s diagnosis and treatment of infectious diseases.

What are the essentials being missed out on? What is the real role of probiotics strains, prebiotics and symbiotic in influencing a health? How do you standardize microbiome analysis?

Witness the major breakthroughs of microbiome, probiotics and prebiotics research along with their applications pertaining to challenges like medicinal data interpretation, investment and regulatory hurdles faced by the practitioners. The intersection between emerging technology and discovery with the context of consumer interest. Detect the non-identified dysbiosis, to discover the potential areas under study for investments in Gut and Skin microbiome and its role as a diagnostic tool of pharmaceutical discovery.

The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th February 2020 in San Diego, CA would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics areas. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

District cooling is one of the nine strategic pillars in Dubai Supreme Council of Energy’s Demand Side Management strategy, towards achieving 30% power savings in the emirate by 2030. The major steps for enhancing district cooling adoption includes planning and educating the top players in real estate firms on the advantages and guiding on the knowledge of technical know-how.

This conclave aims to provide a platform to experts from Government bodies, regulatory authorities, real estate firms, special economic zones, hotel owners and operators, free zones from UAE and rest of GCC and solution providers.

With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities. Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, this year’s congress will hold discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation.

Improving clinical translation in neuroscience research has always been a major challenge until now. There are many research collaborations happening in the neuroscience space today for neurodegenerative disorders research. The conference will focus on discussing the latest technologies in the preclinical, translational neuroscience space and also drawing the attention of the audience towards new innovations happening in translational neuroscience imaging. The conference further aims to bring in the experts from academia and industry together to discuss how to create new, more effective translational neuroscience drawing on novel technology and recent discoveries.

While most of the molecular studies focus over mutational analysis, epigenetics-is the only science which is gaining momentum with its cheaper and faster technology, by making its way to the clinic. Moving on the path of clinical epigenetics, this congress will discuss the solutions to challenges like, drug discovery, identification of molecular inhibitors, gene modification and analysis.

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon. The conference will address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

Focused on the impact of two technologies on manufacturers, our conference is going one step further by addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world.

The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Bispecific Antibodies and Cell Therapies. Clinical trials have showed that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy. It’s clearly one of the hottest fields of Biopharma which has gained momentum in the past few years.

What’s your role in Business Strategies? Are you struggling to stay ahead in the competition? How do you adhere to the gap between strategic intelligence and decision making?

Aimed to position you and your company ahead of the competition,MarketsandMarkets Competitive and Market Intelligence Summit will establish business intelligence that pertains to the best business strategies identifying the right fuel to shoot your strategic decision making. Discover advances in Market Intelligence/Competitive Intelligence/Business Intelligence tools & techniques from world's leading strategists across various industries along with use case implications, best outcome envisions and proactive strategy development. 

In a constantly evolving innovative time, companies continue to wrestle for deriving more value from their “business and corporate strategies”. The significance of a business strategy relies on it being a viable way to build up business desires, creating a competitive advantage and additionally increment shareholder value to something beyond the aggregate of its physical resources. MarketsandMarkets Chief Strategy Officer Forum invites leading strategy executives from Fortune 2000 companies who are making the future.

Drug product development for highly potent APIs (HPAPIs) can be challenging. Complications with the interface between operations in drug substance and drug product handling can result in increased program complexity and cost. The growth in this market is driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, increasing focus of leading pharmaceutical companies on HPAPIs, advancements in HPAPI manufacturing technologies, and growing focus on precision medicine. This year’s conference will focus on case studies related to development, rapid scaling, validation and commercial production of HPAPI drug substance, as well as integrated containment requirements for particle engineering and drug product.

Artificial Intelligence (AI) is changing the ecosystem in the automotive industry along with other applications in everyday life in 21st Century. The battleground to win the customers is one of driving force for automotive manufacturers and OEMs to adopt the new technology and lead the marketplace. After the success of inaugural congress held in Silicon Valley in May 2018, this year, we are aiming to provide a platform to experts from automotive industry, academia, and government institutions discussing the innovations, challenges, and future aspects of innovative technologies in automotive.

Biomarker is constantly evolving as the latent for the development of innovative drugs and diagnostic assays for early detection of disease. The major developments are witnessed in immune therapies where breakthroughs will be appearing soon.

The 4th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 7th-8th February 2019 in San Diego, CA would address the gaps between early stage biomarker development and the commercialization stage of biomarkers. Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

The next big question in cancer immunotherapy is what’s next in immuneoncology?
Overcoming resistance to various combinatorial approaches, selecting the patients and developing translational hypothesis besides designing optimal preclinical models for immunological agents, different strategies to regulate the microbiome are some of the major challenges faced by cancer research experts in the US.

Following the success of our UK Edition, MarketsandMarkets is proud to announce the Next Gen Immuno-Oncology Congress-US Edition to be held on 21st and 22nd June 2018 in Philadelphia, USA. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to address the latest updates in development of CAR-T cell therapy, neoantigen-based and microbiomederived immunotherapy and new paradigms in immune checkpoint inhibitors